MOA Biotech ApS: Financial statements 2022
CVR: 38844679
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MOA Biotech ApS (CVR 38844679) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,500 and a net result of DKK -17,120 compared with DKK -7,812 the year before. Equity in the 2022 report amounted to DKK 22,687. The solvency ratio was 81.9%.
- Gross Profit
- DKK -6,500
- Profit/Loss
- DKK -17,120
- Equity
- DKK 22,687
- Total Assets
- DKK 27,686
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -7 t. | -17 t. | 23 t. | - |
| 2021 | - | -8 t. | -8 t. | 40 t. | - |
| 2020 | - | -8 t. | -8 t. | 48 t. | 0 |
| 2019 | 40 t. | 30 t. | 30 t. | 56 t. | - |
Official annual report
Keep an eye on MOA Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MOA Biotech ApS has published its annual report for 2021. Gross profit came to DKK -7,812, and the net result was DKK -7,812.
About MOA Biotech ApS
MOA Biotech ApS is a Danish company of the type Anpartsselskab based in Odense S, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Østergaard Andersen. The company is owned by Morten Østergaard Andersen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,297 and a net result of DKK -9,297 compared with DKK -8,899 the year before. Equity in the 2025 report amounted to DKK 1,121.